Jamie H. McKinzie

LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders

Linda M. Rorick‐Kehn, Jeffrey M. Witkin, Michael A. Statnick et al. · Neuropharmacology · 2013 · 148 citations

Psychoactive Drug, Psychiatry, Functional Selectivity +7

Chemotherapy of pancreatic cancer with the monoterpene perillyl alcohol

Michael J. R. Stark, Yvette D. Burke, Jamie H. McKinzie et al. · Cancer Letters · 1995 · 137 citations

Oncology, Pancreatic Cancer, Medicine +3

Determination of [35S]Guanosine-5′-O-(3-thio)Triphosphate Binding Mediated by Cholinergic Muscarinic Receptors in Membranes from Chinese Hamster Ovary Cells and Rat Striatum Using an Anti-G Protein Scintillation Proximity Assay

Neil W. DeLapp, Jamie H. McKinzie, Barry D. Sawyer et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 117 citations

κ‐Opioid receptors control the metabolic response to a high‐energy diet in mice

Traci A. Czyzyk, Rubén Nogueiras, John Lockwood et al. · The FASEB Journal · 2009 · 85 citations

Food Intake, Gastrointestinal Peptide Hormone, Obesity +22

Effects of the antitumor agent perillyl alcohol on H-Ras vs. K-Ras farnesylation and signal transduction in pancreatic cells.

Keitch R. Stayrook, Jamie H. McKinzie, L H Barbhaiya et al. · PubMed · 1998 · 45 citations